28
Oct
2025
ADCHEM International FZCO
Exhibitor at CPHI Frankfurt 2025 stand 8.0S12, Excipients
About Us
Categories
-comp271957.png)
-
AE -
2018On CPHI since
-
100 - 249Employees
Company types
Contact info
-
-
-
Unit #B3SR07, Jebel Ali Free Zone, South, 341257, DUBAI, United Arab Emirates
Event information
CPHI Frankfurt 2025
-
28 Oct 2025 - 30 Oct 2025
-
Messe, Frankfurt
-
Visit us at stand 8.0S12, Excipients
Products Featured at CPHI Frankfurt 2025
-
Product Atorvastatin
Atorvastatin is an HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke -
Product Dapagliflozin
Dapagliflozin is a prescription medication that is mainly used alongside diet and exercise to help treat type 2 diabetes, but it is also used in the treatment of heart failure. -
Product Empagliflozin
Empagliflozin is a medication used in the management and treatment of type 2 diabetes mellitus. It is in the sodium-glucose co-transporter (SGLT-2) class of medication for diabetes -
Product Metformin
Metformin is a biguanide antihyperglycemic used in conjunction with diet and exercise for glycemic control in type 2 diabetes mellitus -
Product Sitagliptin
API Molecular formula -
C16H15F6N5O
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance